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Abstract
Background: Hypoxia plays an important role in vascular remodeling and directly affects vascular smooth muscle
cells (VSMC) functions. Macrophage migration inhibitory factor (MIF) is a well known proinflammatory factor, and
recent evidence suggests an important role of MIF in the progression of atherosclerosis and restenosis. However,
the potential link between hypoxia and MIF in VSMC has not been investigated. The current study was designed
to test whether hypoxia could regulate MIF expression in human VSMC. The effect of modulating MIF expression
on hypoxia-induced VSMC proliferation and migration was also investigated at the same time.
Results: Expression of MIF mRNA and protein was up-regulated as early as 2 hours in cultured human VSMCs after
exposed to moderate hypoxia condition (3% O2). The up-regulation of MIF expression appears to be dependent on
hypoxia-inducible transcription factor-1a(HIF-1a) since knockdown of HIF-1a inhibits the hypoxia induction of MIF
gene and protein expression. The hypoxia induced expression of MIF was attenuated by antioxidant treatment as
well as by inhibition of extracellular signal-regulated kinase (ERK). Under moderate hypoxia conditions (3% O2),
both cell proliferation and cell migration were increased in VSMC cells. Blocking the MIF by specific small
interference RNA to MIF (MIF-shRNA) resulted in the suppression of proliferation and migration of VSMCs.
Conclusion: Our results demonstrated that in VSMCs, hypoxia increased MIF gene expression and protein
production. The hypoxia-induced HIF-1a activation, reactive oxygen species (ROS) generation and ERK activation
might be involved in this response. Both MIF and HIF-1a mediated the hypoxia response of vascular smooth
muscle cells, including cell migration and proliferation.
Background
Tissue hypoxia is an essential feature of chronic inflam-
matory diseases. In the cardiovascular system, for exam-
ple, when arterial wall thickens and blood-diffusion
capacity is low in atherosclerotic lesions, hypoxia plays a
key role in the development of atherosclerosis [1,2]. The
cellular effects of hypoxia are primarily mediated by the
hypoxia-inducible transcription factor-1 (HIF-1). It is a
heterodimeric transcription factor composed of a and b
subunits. HIF-1b is constitutively expressed in many
cell types. HIF-1a, the active subunit of HIF-1, is
undetectable under normoxia because of rapid proteaso-
mal degradation. But it is stabilized under hypoxia con-
ditions [3]. HIF-1 specifically binds hypoxic response
element (HRE)-driven promoters on a number of genes
such as vascular endothelial growth factor (VEGF),
heme oxygenase and erythropoietin. In human athero-
sclerosis, HIF-1a protein co-localizes with macrophages
[2]. HIF-1a may play a role in foam cell formation [4].
Evidences suggest that the HIF-1 pathway is associated
with the progression and angiogenesis of human athero-
sclerosis [2,5,6]. Recent studies have shown that in nor-
mal oxygen conditions, G-protein-coupled receptor
agonists including angiotensin II [7,8] and thrombin [9],
potently induce and activate HIF-1a in vascular smooth
muscle cells. These results suggest a more general role
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injury. However, the role of hypoxia and HIF-1 in ather-
osclerosis remains largely unknown.
Recently, macrophage migration inhibitory factor
(MIF) has emerged as a key factor in vascular remodel-
ing and in the development and progression of athero-
sclerosis [10-13]. MIF is an essential, upstream
component of the inflammatory cascade and has a criti-
cal role in several inflammatory conditions [10]. It can
be expressed by vascular endothelial cells, VSMCs and
macrophages. Increased expression of vascular MIF is
associated with foam cell transformation during athero-
genesis. MIF is expressed in atherosclerotic lesions, and
has been suggested to be involved in atherosclerotic pla-
que development [12]. Several pro-atherosclerotic med-
iators such as oxidized LDL [14], CD40-L and
angiotensin II are able to stimulate MIF expression [12].
However, the regulation of MIF expression in vascular
cells, and its mechanisms of action have received little
attention in atherosclerosis research.
MIF has recently been shown to be up-regulated by
hypoxia in several tumor cell types in vitro including
breast carcinoma cells [15,16]. However, there are few
data about the direct effects of hypoxia on the expres-
sion of MIF in VSMCs. VSMCs are one of the major
constituents of blood vessels. VSMCs are also essential
to atherosclerotic lesions. In the view of the increased
expression of MIF in the atherosclerosis, we hypothe-
s i z e dt h a tM I Fm i g h tb eu p - r e g u l a t e db yh y p o x i ai n
VSMCs, and the up-regulation of MIF could be
mediated via HIF-1 dependent pathway. In order to test
our hypothesis, we examined the influence of hypoxia
on the MIF expression in human VSMCs. Primary
human umbilical artery smooth muscle cells
(HUASMCs) were used as a model to study the effects
of hypoxia on the expression of MIF modulated by RNA
interference in this study.
Results
Hypoxia increases MIF expression in cultured vascular
smooth muscle cells
It was reported that hypoxia (1% O2) stimulation could
induce MIF expression in breast cancer cell line [16].
However, exposure to hypoxia (1% O2) reduced cell pro-
liferation and increased apoptotic cell death in VSMC
[17]. Therefore, in our present study, in order to test
the effect of hypoxia on the MIF expression, different
degrees of hypoxia (10, 5, or 3% O2,b u tn o t1 %O 2)
were used.
MIF mRNA expression was evaluated by quantitative
RT-PCR in HUASMCs exposed to different oxygen level
for different time. As shown in Figure 1A, hypoxia at
3% oxygen for 2 h significantly induced MIF mRNA
expression, whereas hypoxia at 5 and 10% oxygen had
n oe f f e c to nM I Fg e n ee x p r e s s i o n .T h ei n d u c t i o nw a s
peaked at 24 h after exposure to hypoxia (3% O2).
We then used 3% oxygen treatment for 24 h as hypoxia
stimulation in the following experiments.
We next examined whether MIF protein production
was regulated in response to hypoxia by Western Blot
and ELISA. The cells were exposed to hypoxia for indi-
cated times. Subsequently, the secretion of MIF in the
culture media was measured by ELISA. Under normoxia
condition, growth-arrested HUASMCs expressed low
level of MIF protein. Our data showed that 3% oxygen
induced maximum MIF protein expression at 24 h (Fig-
ure 1B). Similarly, under normoxia condition,
HUASMCs only expressed low level MIF protein as
detected by Western blot. Total cellular MIF protein
levels began to increase 2 h after exposure to 3% O2,
and peaked at 24 h (Figure 1C). These data suggest that
hypoxia induces both MIF mRNA and protein produc-
tion in HUASMCs.
Hypoxia stimulation (3% O2) induces expression and
activation of HIF-1a in cultured vascular smooth muscle
cells
HIF-1a is the key master regulator to hypoxic response
[3], so we observed the possible role of HIF-1a in our
experimental model. HIF-1a mRNA and protein levels
were highly induced in HUASMCs exposed to hypoxia
(3% O2) for 24 h, coincident with the expression of MIF
(Figure 2A and 2B).
In order to further validate that HIF-1a could be acti-
vated by the hypoxia stimulation (3% O2), we next per-
formed electrophoretic mobility shift assay (EMSA)
experiments aimed at assessing whether HIF-1a DNA
binding activity can be induced under 3% O2 hypoxia
conditions. EMSA assay was performed using primers
encompassing the hypoxia response element (HRE) and
adjacent flanking regions in the promoter of human
MIF gene [18]. Our data showed that HIF-1a binding
activity could be increased by exposure to hypoxia (3%
O2) for 24 h (Figure 2C).
The hypoxia-induced MIF expression in cultured vascular
smooth muscle cells is dependent on HIF-1a pathway
Next, we investigated whether HIF-1a was involved in
hypoxia-induced MIF upregulation in HUASMCs. To
block HIF-1a actions, we used a HIF-1a-specific small
inhibitory RNA construct (HIF-1a-siRNA) to knock-
down HIF-1a expression. The specific HIF-1a-siRNA
expressing plasmid was constructed and used to knock-
down HIF-1a expression in the lung cancer cell line
A549 cells in our previous report [19]. In order to con-
firm the inhibition effect of HIF-1a-siRNA expressing
plasmid, we determined the gene and protein expression
of HIF-1a in HUASMCs after transfection. As shown in
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Page 2 of 12Figure 1 Hypoxia increases MIF mRNA expression (A) an dp r o t e i np r o d u c t i o n( B ,C )i nH U A S M C s . Growth-arrested HUASMCs were
exposed to hypoxia for different durations. (A) Quantitative RT-PCR (Q-PCR) results. Total cellular RNA was isolated from normoxia or hypoxia-
stimulated cells. After reverse transcription, they were subjected to quantitative PCR analysis to determine MIF mRNA level. Graph is
representative of relative MIF mRNA levels in the various conditions (n = 3 in each group). * indicates P < 0.05 vs control cells under normoxia.
(B) Release of MIF protein measured by ELISA. Growth-arrested cells were exposed to hypoxia (3% O2) for different durations, and MIF protein
released into cell culture media was measured by ELISA (n = 3 in each group). * indicates P < 0.05 vs control cells under normoxia. (C)
Expression of MIF protein detected by Western blot. Western Blot detecting of MIF expression in control HUASMCs under normoxia or hypoxia
(3% O2) for different durations. Representative Western blot (top) and values of MIF production (mean ± SEM of 3 experiments, bottom). Results
of MIF protein production were obtained from densitometric analysis and expressed as ratio of MIF/b-actin. * P < 0.05 vs control cells under
normoxia.
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Page 3 of 12Figure 3A, the hypoxia-induced expression of HIF-1a
mRNA was significantly suppressed in HUASMCs trans-
fected with HIF-1a-siRNA vector. Accordingly, HIF-1a
protein level was decreased in cells receiving HIF-1a-
siRNA (Figure 3B). Transfection of HUASMCs with a
wild-type HIF-1a expression vector led to up-regulation
HIF-1a at both the mRNA and protein level under nor-
moxic and hypoxic conditions (Figure 3).
Silencing HIF-1a expression by HIF-1a-siRNA signifi-
cantly inhibited hypoxia-induced MIF gene and protein
expression in HUASMC, as evaluated by quantitative
PCR, Western blot and ELISA (Figure 4). As a negative
control, the scrambled-siRNA had no effect on MIF
expression in HUASMCs. Furthermore, in order to con-
firm that HIF-1a specifically induced MIF expression,
we utilized a wild type HIF-1a expression vector to
over-express HIF-1 during normoxic culture. Over-
expression of HIF-1 stimulated MIF expression in
HUASMCs under normoxia condition. Thus, we con-
clude that: 1) HIF-1a is both necessary and sufficient to
upregulate MIF expression in HUASMCs, and 2) the
hypoxia-induced MIF expression in HUASMCs is most
likely mediated by HIF-1a.
Molecular mechanisms of hypoxia-induced HIF-1a and
MIF expression in HUASMCs
Hypoxia activates several intracellular mediators, such as
intracellular reactive oxygen species (ROS) [9,20] and
extracellular signal-regulated kinase(ERK)[20]. Hypoxia-
induced HIF-1a expression and activation was blocked
by treatment with antioxidant Tiron (4, 5-dihydroxy-1,3-
benzene disulfonic acid, a widely used antioxidant), and
PD98059 (inhibitor of ERK signaling)(Figure 2), indicat-
ing that activation of ERK signaling and reactive oxygen
species generated in response to hypoxia are essential in
this process.
Exogenous hydrogen peroxide (H2O2), a reactive oxy-
gen species (ROS), has been reported to increase MIF
expression in normal rat neurons [21]. In our study, we
observed that the hypoxia-induced MIF gene expression
and protein production was markedly abrogated when
the O
2- scavenger Tiron was incubated with HUASMCs
exposed to hypoxia stimulation. Moreover, inhibition of
ERK by its specific inhibitor PD98059 significantly
decreased hypoxia-induced MIF expression at both gene
and protein levels (Figure 5). These findings suggest that
hypoxia-induced MIF expression in HUASMCs is
mediated by reactive oxygen species and extracellular
signal-regulated kinase signaling.
Role of MIF in the hypoxia-induced proliferation of
HUASMCs
In order to examine if MIF plays a role in hypoxia-
induced cell proliferation, we used bromodeoxyuridine
Figure 2 Hypoxia stimulation (3% O2) induces expression and
activation of HIF-1a in cultured HUASMCs. (A) Hypoxia (3% O2)
induces HIF-1a mRNA expression. Total cellular RNA was isolated
from control HUASMCs under normoxia or hypoxia-stimulated cells
in the presence or absence of inhibitors. After reverse transcription,
they were subjected to quantitative PCR analysis to determine HIF-
1a mRNA level. Graph is representative of relative HIF-1a mRNA
levels in the various conditions (n = 3 in each group). * indicates P
< 0.05 vs control cells under normoxia. # P < 0.05 vs cells exposed
to hypoxia for 24 h. PD98: PD98059. (B) Hypoxia (3% O2) increases
HIF-1a protein levels. Western Blot detecting of HIF-1a protein
expression in control HUASMCs under normoxia or cells exposed to
hypoxia (3% O2) in the presence or absence of inhibitors.
Representative Western blot (top) and values of HIF-1a production
(mean ± SEM of 3 experiments, bottom). Results of HIF-1a protein
production were obtained from densitometric analysis and
expressed as ratio of HIF-1a/b-actin. * P < 0.05 vs control cells
under normoxia. # P < 0.05 vs cells exposed to hypoxia for 24 h.
PD98: PD98059. (C) Hypoxia increases HIF-1a DNA binding activity
(EMSA results). Representative electrophoretic mobility shift assay
(EMSA) showing protein binding to the HIF-1a oligonucleotide in
nuclear extracts of HUASMCs after hypoxia stimulation in the
presence or absence of inhibitors. Similar results were found in
another two independent experiments.
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Page 4 of 12Figure 3 Knockdown of HIF-1a mRNA and protein expression by RNA interference in HUASMCs. Growth-arrested HUASMCs were
transfected with wild type HIF-1a, HIF-1a-siRNA or scrambled siRNA expressing plasmids for 24 h and then exposed to normoxia or hypoxia
(3% O2) for 24 h. (A) Inhibition HIF-1a mRNA expression in HUASMCs by siRNA. HIF-1a mRNA expression were assayed by Q-PCR (n = 3 in each
group). *P < 0.05 vs control or scrambled siRNA transfection under hypoxia. # P < 0.05 vs control cells under normoxia or hypoxia conditions. (B)
Suppression and over-expression of HIF-1a: western blot analysis. Representative Western blot (top) and values of HIF-1a production (mean ±
SEM of 3 experiments, bottom). Results of HIF-1a protein production were obtained from densitometric analysis and expressed as ratio of HIF-
1a/b-actin. *P < 0.05 vs control or scrambled siRNA transfection under hypoxia. # P < 0.05 vs control cells under normoxia or hypoxia conditions.
HIF-1: wild type HIF-1a plasmid transfection; Scrambled-siRNA: scrambled-siRNA plasmid transfection; HIF-1a-siRNA: HIF-1a-siRNA plasmid transfection.
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Page 5 of 12Figure 4 Hypoxia induces MIF mRNA (A) and protein levels (B,
C) via HIF-1a pathway in HUASMCs. Growth-arrested HUASMCs
were transfected with wild type HIF-1a, HIF-1a-siRNA or scrambled
siRNA expressing plasmids for 24 h and then exposed to normoxia
or hypoxia (3% O2) for 24 h. (A) Real-time PCR results. MIF mRNA
expression were assayed by Q-PCR (n = 3 in each group). * P < 0.05
vs control cells under normoxia. # P < 0.05 vs control or scrambled
siRNA transfection under hypoxia. (B) ELISA results. MIF protein
released into cell culture media was measured by ELISA (n = 3 in
each group). * indicates P < 0.05 vs control cells under normoxia. #
P < 0.05 vs control or scrambled siRNA transfection under hypoxia.
(C) Western blot results. Representative Western blot (top) and
values of total MIF production (mean ± SEM of 3 experiments,
bottom). Results of total MIF protein production were obtained
from densitometric analysis and expressed as ratio of MIF/b-actin. *
indicates P < 0.05 vs control cells under normoxia. # P < 0.05 vs
control or scrambled-siRNA transfection under hypoxia. HIF-1: wild
type HIF-1a plasmid transfection; Scrambled-siRNA: scrambled-siRNA
plasmid transfection; HIF-1a-siRNA: HIF-1a-siRNA plasmid transfection.
Figure 5 Molecular mechanisms involved in hypoxia-induced
MIF up-regulation. Cells were pretreated with ERK inhibitor
(PD98059, 10
-6 mol/L), or anti-oxidant (Tiron, 5 mmol/L) and then
exposed to hypoxia (3% O2) for 24 hours. In some experiments, cells
were transfected with MIF-siRNA for 24 h and then exposed to
normoxia or hypoxia (3% O2) for 24 h. (A) Real-time PCR results. MIF
mRNA expression were assayed by Q-PCR (n = 3 in each group). *
indicates P < 0.05 vs control cells under normoxia. # P < 0.05 vs
control cells under hypoxia. (B) ELISA results. MIF protein released
into cell culture media was measured by ELISA (n = 3 in each
group). * indicates P < 0.05 vs control cells under normoxia. # P <
0.05 vs control cells under hypoxia. (C) Western blot results.
Representative Western blot (top) and values of total MIF
production (mean ± SEM of 3 experiments, bottom). Results of total
MIF protein production were obtained from densitometric analysis
and expressed as ratio of MIF/b-actin. * indicates P < 0.05 vs control
cells under normoxia. # P < 0.05 vs control cells under hypoxia.
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Page 6 of 12(Brdu) incorporation assay[22,23] to study the prolifera-
tion of growth-arrested HUASMCs followed by co-treat-
ment with specific MIF-siRNA (Santa Cruz Biotech,
USA) and hypoxia (3% O2) for 24 h. The specific MIF-
siRNA could significantly inhibit MIF expression in
HUVSMCs under both normoxia and hypoxia condi-
tions (Figure 5).
Figure 6A shows that, similar with the other report
[17] in which exposure to hypoxia (3% O2) stimulated
the proliferation of cultured vascular cells, exposure to
hypoxia for 24 h increased HUASMCs cell proliferation
by 113.6% compared to the cells cultured under nor-
moxia conditions. The siRNA duplex specific to MIF
(MIF-siRNA) partly prevented the increase in cell prolif-
eration both under hypoxia (41.5% inhibition) and in
normoxia (61.6% inhibition) (Figure 6A). Furthermore,
the proliferation of HUASMCs was completely sup-
pressed in HIF-1a-knockdown cells exposed to hypoxia,
while it was significantly enhanced in HIF-1a-over
expressing cells. Our data indicated that MIF was
involved in basal and hypoxia-induced HUASMC
proliferation
Role of MIF in hypoxia-induced migration in HUVSMCs
To examine the effect of MIF in VSMC migration in
response to hypoxia, HUASMCs were incubated in a
Boyden chamber under normoxic or hypoxic conditions,
in the absence or presence of specific siRNA to MIF
(MIF-siRNA). As shown in Figure 6B, HUASMCs
migrated significantly through the filter membrane
under hypoxia (3% O2) for 24 h. The MIF-siRNA partly
prevented this increase in cell migration both under
hypoxia (27.7% inhibition) and in normoxia (47.7% inhi-
bition). Over-expression of HIF-1a could enhance the
HUASMC migration under normoxia, whereas knock-
down of HIF-1a expression in HUASMCs abolished
hypoxia-induced migration in these cells. Our data
demonstrate that MIF not only involves in controlling
the baseline migration in normoxia condition, but also
mediates migration of VSMC in response to hypoxia.
Discussion
In the present study, the potential correlation between
hypoxia and MIF expression was investigated in cultured
HUASMCs. The major findings of this study are: (1)
hypoxia at 3% O2, but not 5 or 10% oxygen, up-regu-
lates MIF expression in VSMCs; (2) transcription factor
HIF-1a is necessary and sufficient in the signaling path-
way of MIF induction under hypoxia; (3) enhanced gen-
eration of reactive oxygen species (ROS) and activation
of extracellular signal-regulated kinase (ERK) might be
important in mediating the hypoxia-induced expression
of HIF-1a and MIF; (4) blockade of MIF results in the
inhibition of hypoxia-induced proliferation and
migration in the HUASMC cells. Our data clearly indi-
cate that moderate hypoxia plays a crucial role in the
modulation of MIF expression in VSMCs. These obser-
vations also establish a role of MIF in mediating
hypoxia-induced proliferation and migration in vascular
smooth muscle cells. In addition, our results suggest
that inhibition of MIF might be useful for preventing
abnormal VSMC proliferationa n dm i g r a t i o ne v o k e db y
hypoxia.
Both MIF and hypoxia play critical roles in inflamma-
tion and atherosclerosis. MIF has been identified as a
hypoxia-induced gene in cancer cells. Recent evidences
show that MIF is up-regulated by hypoxia (1% O2)i n
human cancer cells, such as colon tumor cells [24]and
breast carcinoma cells [15]. Moreover, MIF mRNA
expression is induced in a HIF-dependent manner in
HeLa cells [16]. However, by using siRNA approach,
Larsen et al [15] reported that MIF regulation in MCF-7
breast cancer cells is due to other hypoxia-induced regu-
latory mechanisms, independent of HIF-1 and HIF-2
activation. Consistent with previous report [9], we
observed that HIF-1a mRNA and protein expression
and DNA binding activity could be induced in
HUASMCs exposed to hypoxia stimulation (3% O2). In
our experimental model, over-expression of HIF-1a,t h e
key transcription factor activated during hypoxia, was
able to up-regulate MIF gene and protein expression
under normoxia, whereas knockdown of HIF-1a expres-
sion in HUASMCs inhibited hypoxia-induced MIF
expression. Our data demonstrate that, in cultured
HUASMCs, hypoxia (3% O2) increased MIF expression
and synthesis via the HIF-1a pathway, suggesting that
the mechanism involved in up-regulation of MIF expres-
sion is dependent on cell type.
HIF-1 regulation by non-hypoxic stimuli has gained
considerable interest [8,9]. In addition to angiotensin II
and thrombin [8], studies have showed that HIF-1a sta-
bilization and activation is also induced by several pro-
inflammatory cytokines, such as IL-1 and TNFa [25,26].
As a regulator of MIF expression, HIF-1a might be of
potential importance during inflammatory diseases. It is
reported that MIF regulates HIF-1 activity in a p53-
dependent manner in human cancer cells[27]. There-
fore, whether MIF could activate HIF-1a transcriptional
activity in VSMCs needs further studies.
Activation of several signaling pathways such as ERK
might mediate HIF-1a activation [20] and MIF expres-
sion [28]. By using a specific inhibitor, the present
observations demonstrate that hypoxia upregulates MIF
via activation of ERK in HUVSMCs. Another pathway
implicated in the hypoxia induced response is the gen-
eration of intercellular ROS [9,20]. Our results showed
that the antioxidant Tiron, a cell permeable scavenger of
ROS, partially blocks MIF production elicited by
Fu et al. BMC Cell Biology 2010, 11:66
http://www.biomedcentral.com/1471-2121/11/66
Page 7 of 12Figure 6 MIF is involved in hypoxia-induced proliferation and migration of cultured HUASMCs.G r o w t h - a r r e s t e dH U A S M C sw e r e
transfected with wild type HIF-1a, HIF-1a-siRNA, MIF-siRNA or scrambled siRNA for 24 h and then exposed to normoxia or hypoxia (3% O2) for
24 h. (A) Cell proliferation measured by BrdU assay (n = 6 in each group). * indicates P < 0.05 vs control cells under normoxia. # P < 0.05 vs
control or scrambled siRNA transfection under hypoxia. (B) Migration of cultured HUASMCs (n = 3 in each group). * indicates P < 0.05 vs control
cells under normoxia. # P < 0.05 vs control or scrambled siRNA transfection under hypoxia.
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Page 8 of 12hypoxia, suggesting that ROS acts as intermediates of
hypoxia-induced MIF expression.
VSMCs proliferation and migration that respond to
vascular injury contribute to vessel narrowing and play
an important role in the atherosclerotic process. It has
been recognized that hypoxia is a stimulus to VSMCs
proliferation and migration, a process known as the vas-
cular remodeling [29,30]. Hypoxia plays an important
role in vascular remodeling and directly affects VSMCs
functions. Some growth factors, such as PDGF [31] and
VEGF [29], are involved in the hypoxia-induced prolif-
eration of VSMCs. Consistent with previous reports
[23,31], we observed that HIF-1a is essential to VSMC
proliferation exposed to hypoxia. Moreover, our results
s h o wt h a tt h es p e c i f i cM I F - s i R N Ap a r t i a l l yb l o c k s
HUASMCs proliferation elicited by hypoxia, suggesting
that MIF acts as one of the mediators of hypoxia-
induced VSMC proliferation.
In addition to proliferationo fV S M C sw i t h i nt h ev e s -
sel wall, the migration of VSMCs from the media into
the neointima is another important feature in the patho-
genesis of atherosclerosis [5,32,33]. This process is regu-
lated by multiple factors, and MIF is one of the multiple
factors that could increase VSMCs migration[33]. MIF
is an important mediator of vessel wall remodeling and
acts on the migration of VSMCs in an autocrine and
paracrine manner[33]. Previous report shows that
hypoxia induces the migration of human coronary artery
smooth muscle cells, and the migration is elicited by
thrombospondin-1[34]. In the present study, treatment
of HUASMCs with the specific MIF-siRNA abolished
hypoxia-induced migration, suggesting a role for MIF in
the migration of VSMCs in response to hypoxia. Alto-
gether, our data demonstrate that HIF-1a and MIF are
both important mediators of vascular cell proliferation
and migration.
Conclusions
In summary, we showed that hypoxia, and specifically
HIF-1a, might be a potent and rapid inducer of MIF
expression in human VSMCs. The specific MIF-siRNA
could suppress both basal and hypoxia-induced prolif-
e r a t i o na n dm i g r a t i o no fV S M C s .I nv i e wo ft h ei m p o r -
tant role of MIF and hypoxia to atherosclerosis, our
findings might contribute to the understanding of the
pathogenesis of progressive atherosclerosis.
Methods
Vascular smooth muscle cell culture
Primary cultures of HUASMCs were isolated from freshly
delivered umbilical cords by tissue explanting method
[35,36] and maintained in DMEM medium (GIBCO-
BRL) supplemented with 20% fetal bovine serum (FBS)
(Hyclone), 2 mmol/L L-glutamine, and 1% penicillin-
streptomycin. All cell cultures were maintained in a
humidified 5% CO2/95% air incubator at 37°C. When
confluent, HUASMCs were passaged every 6-7 days after
trypsinization and were used for experiment from
the third to sixth passages. HUASMCs were identified by
the specific marker of vascular smooth muscle cell
(a-smooth muscle actin, a-SMA) immunofluorescence.
The study was conducted according to the Declaration
of Helsinki. The study was reviewed and approved by
the medical ethics committee of the West China Hospi-
tal, Sichuan University.
Hypoxia stimulation
A humidified temperature controlled incubator model
IG 750 (Jouan, Saint-Nazaire, France) was used as a
hypoxic chamber. For hypoxia conditions, the concen-
tration of oxygen was reduced to 10, 5, or 3% by repla-
cement with N2,a n dC O 2 w a sc o n s t a n ta t5 % .C o n t r o l
was defined as 95% air and 5% CO2.
HUASMCs were seeded in the 60 mm plates (Corn-
ing, NY, USA). All cells were grown to 90% confluence
under normoxic conditions. The media was then chan-
ged, pretreated in starving conditions (normal culture
media without FBS) for 24 h before exposure to
hypoxia. Experiments were carried out with three repli-
cates for each data point. In some experiments, cells
were pre-treated for 30 minutes with 10
-6 mol/L
PD98059, or 5×10
-3 mol/L Tiron, and then exposed to
hypoxia for 24 h.
RNA interference
HIF-1a target-specific siRNA plasmid vector and a
scrambled siRNA control plasmid were constructed as
our previously described [19]. Constructs expressing
HIF-1a (wild type) were a gift from Professor Cormac
T. Taylor (University College, Dublin, Ireland). Transi-
ent transfections were performed using the cationic
lipid, Lipofectamine™ 2000 (Invitrogen, USA), according
to the manufacturer’s protocols. Cells were plated in
dishes (60 mm in diameter) grown to 90% confluence
prior to transfection. Each dish was transfected with
8.0 μg of plasmid containing HIF siRNA or control
RNA (plasmids containing null mutant HIF-GFP) and
20 μL of Lipofectamine™ 2000. Wild type HIF-1a was
co-transfected with EGFP. Transfection efficiency aver-
aged between 60-70% as measured by green fluorescent
protein expression. Cells were allowed to recover in
DMEM for 6 h after transfection. After the medium
changed, the culture was exposed to normoxia or
hypoxia for 24 h before assays were performed.
In some experiments, cultured HUASMCs were
transfected with 800 ng siRNA duplex specific to MIF
(MIF-siRNA) (Santa Cruz Biotech, USA) according to
the manufacturer’s instruction.
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Page 9 of 12Real-time RT-PCR
The expression of MIF gene was identified by quantita-
tive real time RT-PCR (Q-PCR) as reported earlier [37].
T o t a lR N Aw a se x t r a c t e df r o mH U A S M C sc e l l su s i n g
TRIZOL® reagent (Invitrogen, USA). Q-PCR was carried
o u to na nA B IP r i s m7 3 0 0P C RD e t e c t i o nS y s t e m
(Applied Biosystems, USA) with fluorescence dye SYBR
Green (SYBR Green Real-time PCR Master Mix,
TOYOBO, Japan). The sequences of the primers were as
follows: MIF-F: 5′-GTGCCAGAGGGGTTTCTCTC-3′,
MIF-R: 5′-CAGCAGCTTGCTGTAGTTGC-3′.H I F - 1 a-
F: 5′-CTAGCCGAGGAA GAACTATGAACAT-3′, HIF-
1a-R: 5′-CTGAGGTTGGTTACTGTT GGTATCA-3′.
b-actin-F: 5′-CAACTCCATCATGAAGTGTAAC-3′; b-
actin-R: 5′-CCACACGGA GTACTTGCGCTG-3′.T h e
thermal cycling conditions were as following: 95°C 60
seconds, 40 cycles of 95°C for 15 seconds, 58°C for 15
seconds, 72°C for 45 seconds (data collection). Data ana-
lysis was carried out by ABI sequence detection software
using relative quantification. For quantification, the tar-
get sequence was normalized to the b-actin mRNA
levels.
Western Blot Analysis
Western-blot analysis of MIF and HIF-1a was per-
formed using rabbit polyclonal antibodies against MIF
or HIF-1a (Santa Cruz Biotechnology, Inc., Santa Cruz,
CA, USA), according to the method described before
[38,39]. In brief, HUASMC cells were scraped from
dishes and cellular protein extracts were prepared by
homogenization in an ice-cold RIPA lysis buffer contain-
ing protease inhibitor cocktail (Roche, Indianapolis, IN,
USA). Cell lysates (40 μg) were separated by denaturing
10% SDS-PAGE and then transferred to polyvinylidene
difluoride (PVDF) membrane (Millipore) using a Mini-
Protein III system (Bio-Rad, CA, USA). Transferred pro-
teins were probed with the rabbit polyclonal anti-MIF
or anti-HIF-1a antibody (1:250) and visualized using the
horseradish peroxidase conjugated secondary anti-rabbit
(1:3000; Santa Cruz Biotechnology, Inc) antibody and
ECL solution (Pierce, USA). Equal protein loading was
verified by reprobing the membrane with an anti b-actin
antibody (Santa Cruz Biotechnology, Inc.). For quantifi-
cation purposes, densitometry measurements were per-
formed using Quantity One® image analysis software for
Windows (Bio-Rad). All specific blot values were cor-
rected for b-actin expression.
Quantification of MIF by ELISA
The level of MIF in culture supernatants was measured
by ELISA using ELISA kit (Quantikine ELISA, R&D Sys-
tems, USA) according to manufacturer’s instructions
[15,38]. In each experiment the MIF concentrations was
normalized to cell count.
Preparation of Nuclear Extracts and Electrophoretic
Mobility Shift Assay
Nuclear extracts from HUASMCs were prepared
according to standard protocols [18]. Electrophoretic
mobility shift assay (EMSA) was performed as described
[18], using a 24-bp oligonucleotide probe containing the
HRE with the HIF-1a binding site and adjacent flanking
regions of human MIF gene [18]. The probe was as fol-
lows: 5′-TCTGTACGTGACCACACTCACCTC-3′ (The
consensus core HIF-1a binding sites are boldfaced).
Assessment of cell proliferation
The effect of hypoxia on cell proliferation was deter-
mined by the bromodeoxyuridine (BrdU) incorporation
assay, as described previously [22,23]. Briefly, HUASMC
cells were subcultured in 96-well plates and incubated
with serum-free medium for 24 h in order to synchro-
nize the cells in G0/G1 phase. Quiescent cells were
transfected with wild type HIF-1a,H I F - 1 a-shRNA,
MIF-shRNA or scrambled siRNA for 24 hours, and then
either exposed to normoxia or hypoxia for 24 h. 10 μL
of BrdU (100 μM) was added to each well and incubated
for the last 3 h of treatment. BrdU incorporation was
measured by a colorimetric ELISA kit (Roche, Indiana-
polis, IN, USA). The light absorbance at 450 nm was
detected using ELISA reader (Bio-Rad Model 680, USA).
Cell Migration Assay
The migration of HUASMCs was determined by using a
Matrigel chamber system (BD Biosciences) as previous
reports [34,40]. Briefly, HUASMC cells were incubated
with serum-free medium for 24 h. Quiescent cultures
were transfected with wild type HIF-1a,H I F - 1 a-siRNA,
MIF-siRNA or scrambled siRNA for 24 h. Following
transfection, HUASMCs (1×10
4) were suspended in 0.5
ml of culture medium and added to the upper chamber.
The upper chamber was lodged into the lower chamber
containing 0.75 ml of culture medium. After incubating
at 37°C for 24 h under normoxia or hypoxia conditions,
the cells in the upper side of the filter membrane were
removed with cotton swabs. Then the cells in the lower
side were trypsinized, and the number of cells in the
lower side was counted.
Statistical analysis
The experimental data were expressed as means ± SD.
Group means were compared by ANOVA using the sta-
tistical software program SPSS 10.0 for Windows (Chi-
c a g o ,I L ,U S A ) ,a n dP value < 0.05 was considered
statistically significant in all cases.
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